Apellis Pharmaceuticals Inc Stock, NASDAQ:APLS
100 5th Avenue, Suite A, Waltham, Massachusetts 02451-8703
United States of America
Number of Employees: 476
Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic and complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.